Immunity induced by the radiation-attenuated schistosome vaccine

Parasite Immunology

Volumn 27, Issue 7-8, 2005, Pages 271-280

  Hewitson, James P ^a   Hamblin, P A ^b   Mountford, A P ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cell mediated; Humoral; Innate; Schistosoma; Th1; Vaccination

Indexed keywords

PARASITE ANTIBODY; PRAZIQUANTEL; SCHISTOSOMA VACCINE;

ANIMAL CELL; ANTIGEN SPECIFICITY; CELL PROTECTION; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; EFFECTOR CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHISTOSOMIASIS; TH1 CELL;

ANIMALS; ANTIBODIES, HELMINTH; HUMANS; MICE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; TH1 CELLS; VACCINATION; VACCINES, ATTENUATED;

SCHISTOSOMA;

EID: 25144432777     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00764.x     Document Type: Review

References (103)

1. van der Werf MJ, de Vlas SJ, Brooker S, et al. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003; 86: 125-139.
2. King CH, Dickman K & Tisch DJ. Reassessment of the cost of chronic helminth infection; a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005; 365: 1561-1569.
3. Doenhoff MJ, Kusel JR, Coles GC & Cioli D. Resistance of Schistosoma mansoni to praziquantel: is there a problem? Trans R Soc Trop Med Hyg 2002; 96: 465-459.
4. Wilson RA & Coulson PS. Why don't we have a schistosomiasis vaccine? Parasitol Today 1998; 14: 97-99.
5. Todd CW & Colley DG. Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg 2002; 66: 348-358.
6. Bergquist R, Al-Sherbiny M, Barakat R & Olds R. Blueprint for schistosomiasis vaccine development. Acta Trop 2002; 82: 183-192.
7. Bergquist NR & Colley DG. Schistosomiasis vaccines: research to development. Parasitol Today 1998; 14: 99-104.
8. Capron A, Capron M & Riveau G. Vaccine development against schistosomiasis from concepts to clinical trials. Br Med Bull 2002; 62: 139-148.
9. Dunne DW & Mountford AP. Resistance to infection in humans and animal models. In Schistosomiasis, ed. Mahmoud AAF. London: Imperial College Press; 2001: 121-133.
10. Minard P, Dean DA, Jacobson RH, Vannier WE & Murrell KD. Immunization of mice with cobalt-60 irradiated Schistosoma mansoni cercariae. Am J Trop Med Hyg 1978; 27: 76-86.
11. Murrell KD, Clark S, Dean DA & Vannier WE. Influence of mouse strain on induction of resistance with irradiated Schistosoma mansoni cercariae. J Parasitol 1979; 65: 829-831.
12. Bickle QD, Dobinson T & James ER. The effects of gamma-irradiation on migration and survival of Schistosoma mansoni schistosomula in mice. Parasitology 1979; 79: 209-222.
13. Hsu SY, Hsu HF & Burmeister LF. Schistosoma mansoni: vaccination of mice with highly x-irradiated cercariae. Exp Parasitol 1981; 52: 91-104.
14. Anderson S, Shires VL, Wilson RA & Mountford AP. In the absence of IL-12, the induction of Th1-mediated protective immunity by the attenuated schistosome vaccine is impaired, revealing an alternative pathway with Th2-type characteristics. Eur J Immunol 1998; 28: 2827-2838.
15. Agnew AM, Murare HM & Doenhoff MJ. Specific cross-protection between Schistosoma bovis and S. haematobium induced by highly irradiated infections in mice. Parasite Immunol 1989; 11: 341-349.
16. Ruppel A, Shi YE & Moloney NA. Schistosoma mansoni and S. japonicum: comparison of levels of ultraviolet irradiation for vaccination of mice with cercariae. Parasitology 1990; 101: 23-26.
17. Dean DA, Mangold BL, Harrison RA & Ricciardone MD. Homologous and heterologous protective immunity to Egyptian strains of Schistosoma mansoni and S. haematobium induced by ultraviolet-irradiated cercariae. Parasite Immunol 1996; 18: 403-410.
18. Ford MJ, Bickle QD & Taylor MG. Immunization of rats against Schistosoma mansoni using irradiated cercariae, lung schistosomula and liver-stage worms. Parasitology 1984; 89: 327-344.
19. Soisson LA, Reid GD, Farah IO, Nyindo M & Strand M. Protective immunity in baboons vaccinated with a recombinant antigen or radiation-attenuated cercariae of Schistosoma mansoni is antibody-dependent. J Immunol 1993; 151: 4782-4789.
20. Yole DS, Pemberton R, Reid GD & Wilson RA. Protective immunity to Schistosoma mansoni induced in the olive baboon Papio anubis by the irradiated cercaria vaccine. Parasitology 1996; 112: 37-46.
21. Eberl M, Langermans JA, Frost PA, et al. Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 2001; 69: 5352-5362.
22. Harrison RA, Bickle QD, Kiare S, et al. Immunization of baboons with attenuated schistosomula of Schistosoma haematobium: levels of protection induced by immunization with larvae irradiated with 20 and 60 krad. Trans R Soc Trop Med Hyg 1990; 84: 89-99.
23. Majid AA, Bushara HO, Saad AM, et al. Observations on cattle schistosomiasis in the Sudan, a study in comparative medicine. III. Field testing of an irradiated Schistosoma bovis vaccine. Am J Trop Med Hyg 1980; 29: 452-455.
24. Shi YE, Jiang CF, Han JJ, Li YL & Ruppel A. Immunization of pigs against infection with Schistosoma japonicum using ultraviolet-attenuated cercariae. Parasitology 1993; 106: 459-462.
25. Sher A, Hieny S, James SL & Asofsky R. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. II. Analysis of immunity in hosts deficient in T lymphocytes, B lymphocytes, or complement. J Immunol 1982; 128: 1880-1884.
26. Vignali DA, Crocker P, Bickle QD, Cobbold S, Waldmann H & Taylor MG. A role for CD4+ but not CD5+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Ro 11-3128-terminated infections. Immunology 1989; 67: 466-472.
27. Bickle QD, Andrews BJ, Doenhoff MJ, Ford MJ & Taylor MG. Resistance against Schistosoma mansoni induced by highly irradiated infections: studies on species specificity of immunization and attempts to transfer resistance. Parasitology 1985; 90: 301-312.
28. Aitken R, Coulson PS & Wilson RA. Pulmonary leukocytic responses are linked to the acquired immunity of mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol 1988; 140: 3573-3579.
29. Reynolds SR & Harn DA. Comparison of irradiated-cercaria schistosome vaccine models that use 15- and 50-kilorad doses: the 15-kilorad dose gives greater protection, smaller liver sizes, and higher gamma interferon levels after challenge. Infect Immun 1992; 60: 90-94.
30. Mangold BL & Dean DA. The migration and survival of gamma-irradiated Schistosoma mansoni larvae and the duration of host-parasite contact in relation to the induction of resistance in mice. Parasitology 1984; 88: 249-265.
31. Anderson S, Coulson PS, Ljubojevic S, Mountford AP & Wilson RA. The radiation-attenuated schistosome vaccine induces high levels of protective immunity in the absence of B cells. Immunology 1999; 96: 22-28.
32. James SL, Labine M & Sher A. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. I. Analysis of antibody and T-lymphocyte responses in mouse strains developing differing levels of immunity. Cell Immunol 1981; 65: 75-83.
33. Ratcliffe EC & Wilson RA. The role of mononuclear-cell recruitment to the lungs in the development and expression of immunity to Schistosoma mansoni. Parasitology 1992; 104: 299-307.
34. Mountford AP, Hogg KG, Coulson PS & Brombacher F. Signaling via interleukin-4 receptor alpha chain is required for successful vaccination against schistosomiasis in BALB/c mice. Infect Immun 2001; 69: 228-236.
35. Richter D, Incani RN & Harn DA. Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni. Infect Immun 1993; 61: 3003-3011.
36. Sher A, Hieny S & James S. Mechanisms of protective immunity against S. mansoni infection in mice vaccinated with irradiated cercariae. VI. Influence of the major histocompatibility complex. Parasite Immunol 1984; 6: 319-328.
37. Bickle QD. Studies on the relationship between the survival of Schistosoma mansoni larvae in mice and the degree of resistance produced. Parasitology 1982; 84: 111-122.
38. Mastin AJ, Bickle QD & Wilson RA. Schistosoma mansoni: migration and attrition of irradiated and challenge schistosomula in the mouse. Parasitology 1983; 87: 87-102.
39. Mountford AP, Coulson PS & Wilson RA. Antigen localization and the induction of resistance in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Parasitology 1988; 97: 11-25.
40. Harrop R & Wilson RA. Irradiation of Schistosoma mansoni cercariae impairs neuromuscular function in developing schistosomula. J Parasitol 1993; 79: 286-289.
41. Mountford AP & Wilson RA. Schistosoma mansoni: the effect of regional lymphadenectomy on the level of protection induced in mice by radiation-attenuated cercariae. Exp Parasitol 1990; 71: 463-469.
42. Constant SL, Mountford AP & Wilson RA. Phenotypic analysis of the cellular responses in regional lymphoid organs of mice vaccinated against Schistosoma mansoni. Parasitology 1990; 101: 15-22.
43. Mountford AP, Coulson PS, Pemberton RM, Smythies LE & Wilson RA. The generation of interferon-gamma-producing T lymphocytes in skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni. Immunology 1992; 75: 250-256.
44. Coulson PS & Mountford AP. Fate of attenuated schistosomula administered to mice by different routes, relative to the immunity induced against Schistosoma mansoni. Parasitology 1989; 99: 39-45.
45. Mountford AP, Harrop R & Wilson RA. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immun 1995; 63: 1980-1986.
46. Wales A & Kusel JR. Biochemistry of irradiated parasite vaccines: Suggested models for their mode of action. Parasitol Today 1992; 8: 358-363.
47. Mountford AP & Harrop. Vaccination against Schistosomiasis: The case for lung-stage antigens. Parasitol Today 1998; 14: 109-114.
48. Correa-Oliveira R, Sher A & James SL. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. V. Anamnestic cellular and humoral responses following challenge infection. Am J Trop Med Hyg 1984; 33: 261-268.
49. Wales A, Fukumoto SI, Otieno MF & Kusel JR. Effects of irradiation on surface carbohydrates of larvae of Schistosoma mansoni. Parasitology 1993; 106: 117-125.
50. van Kooyk Y, Engering A, Lekkerkerker AN, Ludwig IS & Geijtenbeek TB. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr Opin Immunol 2004; 16: 488-493.
51. Ramaswamy K, Kumar P & He YX. A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J Immunol 2000; 165: 4567-4574.
52. Chen L, Rao KV, He YX & Ramaswamy K. Skin-stage schistosomula of Schistosoma mansoni produce an apoptosis-inducing factor that can cause apoptosis of T cells. J Biol Chem 2002; 277: 34329-34335.
53. Medzhitov R & Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 1997; 9: 4.
54. Mountford AP & Trottein F. Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol 2004; 20: 221-226.
55. Hogg KG, Kumkate S, Anderson S & Mountford AP. Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 2003; 71: 3563-3571.
56. Riengrojpitak S, Anderson S & Wilson RA. Induction of immunity to Schistosoma mansoni: interaction of schistosomula with accessory leucocytes in murine skin and draining lymph nodes. Parasitology 1998; 117: 301-309.
57. Hogg KG, Kumkate S & Mountford AP. IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int Immunol 2003; 15: 1451-1459.
58. Hall CA, Eugenio MD & Damian RT. Schistosoma mansoni: antigen-presenting cells emigrating from skin exposed to attenuated cercariae activate lymphoid cells and transfer protection in C57B1/6 mice. J Parasitol 2004; 90: 733-739.
59. Crabtree JE & Wilson RA. Schistosoma mansoni: an ultrastructural examination of skin migration in the hamster cheek pouch. Parasitology 1985; 91: 111-120.
60. von Stebut E, Belkaid Y, Nguyen BV, Cushing M, Sacks DL & Udey MC. Leishmania major-infected murine Langerhans cell-like dendritic cells from susceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis. Eur J Immunol 2000; 30: 3498-3507.
61. Angeli V, Faveeuw C, Roye O, et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 2001; 193: 1135-1147.
62. Jenkins SJ, Hewitson JP, Jenkins GR & Mountford AP. Modulation of the host's immune response by schistosome larvae. Parasite Immunol, in press.
63. Capron A, Riveau G, Capron M & Trottein F Schistosomiasis: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol 2005; 21: 143-149.
64. Trinchieri G, Pflanz S & Kastelein RA. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003; 19: 641-644.
65. Jenkins SJ & Mountford AP. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun 2005; 73: 395-402.
66. Hoffmann KF, James SL, Cheever AW & Wynn TA. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 1999; 163: 927-938.
67. Coulson PS. The radiation-attenuated vaccine against schistosomes in animal models: paradigm for a human vaccine? Adv Parasitol 1997; 39: 271-336.
68. Constant SL & Wilson RA. In vivo lymphocyte responses in the draining lymph nodes of mice exposed to Schistosoma mansoni: preferential proliferation of T cells is central to the induction of protective immunity. Cell Immunol 1992; 139: 145-161.
69. Pemberton RM, Smythies LE, Mountford AP & Wilson RA. Patterns of cytokine production and proliferation by T lymphocytes differ in mice vaccinated or infected with Schistosoma mansoni. Immunology 1991; 73: 327-333.
70. Kumar P & Ramaswamy K. Vaccination with irradiated cercariae of Schistosoma mansoni preferentially induce the accumulation of interferon-gamma producing T cells in the skin and skin-draining lymph nodes of mice. Parasitol Int 1999; 48: 109-119.
71. Ratcliffe EC & Wilson RA. The magnitude and kinetics of delayed-type hypersensitivity responses in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Parasitology 1991; 103: 65-75.
72. Caulada-Benedetti Z, al-Zamel F, Sher A & James S. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae. J Immunol 1991; 146: 1655-1660.
73. Coulson PS & Wilson RA. Recruitment of lymphocytes to the lung through vaccination enhances the immunity of mice exposed to irradiated schistosomes. Infect Immun 1997; 65: 42.
74. Coulson PS & Wilson RA. Pulmonary T helper lymphocytes are CD44hi, CD45RB- effector/memory cells in mice vaccinated with attenuated cercariae of Schistosoma mansoni. J Immunol 1993; 151: 3663-3671.
75. Smythies LE, Pemberton RM, Coulson PS, Mountford AP & Wilson RA. T cell-derived cytokines associated with pulmonary immune mechanisms in mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Immunol 1992; 148: 1512-1518.
76. Smythies LE, Coulson PS & Wilson RA. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae. J Immunol 1992; 149: 3654-3658.
77. Wilson RA, Coulson PS, Betts C, Dowling MA & Smythies LE. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 1996; 87: 275-282.
78. Jankovic D, Wynn TA, Kullberg MC, et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J Immunol 1999; 162: 345-351.
79. Oswald IP, Caspar P, Wynn TA, et al. Failure of P strain mice to respond to vaccination against schistosomiasis correlates with impaired production of IL-12 and up-regulation of Th2 cytokines that inhibit macrophage activation. Eur J Immunol 1998; 28: 1762-1772.
80. Wynn TA, Jankovic D, Hieny S, Cheever AW & Sher A. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia. J Immunol 1995; 154: 4701-4709.
81. Wynn TA, Reynolds A, James S, et al. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 1996; 157: 4068-4078.
82. Menson EN & Wilson RA. Lung-phase immunity to Schistosoma mansoni. Flow cytometric analysis of macrophage activation states in vaccinated mice. J Immunol 1989; 143: 2342-2348.
83. Wynn TA, Oswald IP, Eltoum IA, et al. Elevated expression of ThI cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni. J Immunol 1994; 153: 5200-5209.
84. Street M, Coulson PS, Sadler C, et al. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 1999; 163: 4489-4494.
85. James SL & Glaven J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J Immunol 1989; 143: 4208-4212.
86. Ahmed SF, Oswald IP, Caspar P, et al. Developmental differences determine larval susceptibility to nitric oxide-mediated killing in a murine model of vaccination against Schistosoma mansoni. Infect Immun 1997; 65: 219-226.
87. Coulson PS, Smythies LE, Betts C, et al. Nitric oxide produced in the lungs of mice immunized with the radiation-attenuated schistosome vaccine is not the major agent causing challenge parasite elimination. Immunology 1998; 93: 55-63.
88. James SL, Cheever AW, Caspar P & Wynn TA. Inducible nitric oxide synthase-deficient mice develop enhanced type 1 cytokine-associated cellular and humoral immune responses after vaccination with attenuated Schistosoma mansoni cercariae but display partially reduced resistance. Infect Immun 1998; 66: 3510-3518.
89. Crabtree JE & Wilson RA. The role of pulmonary cellular reactions in the resistance of vaccinated mice to Schistosoma mansoni. Parasite Immunol 1986; 8: 265-285.
90. Kambara T & Wilson RA. In situ pulmonary responses of T cell and macrophage subpopulations to a challenge infection in mice vaccinated with irradiated cercariae of Schistosoma mansoni. J Parasitol 1990; 76: 365-372.
91. Wilson RA, Coulson PS & Mountford AP. Immune responses to the radiation-attenuated schistosome vaccine: what can we learn from knock-out mice? Immunol Lett 1999; 65: 117-123.
92. Vignali DA, Klaus SN, Bickle QD & Taylor MG. Histological examination of the cellular reactions around schistosomula of Schistosoma mansoni in the lungs of sublethally irradiated and unirradiated, immune and control rats. Parasitology 1989; 98: 57-65.
93. Sher A, Coffman RL, Hieny S & Cheever AW. Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J Immunol 1990; 145: 3911-3916.
94. King CL, Xianli J, Malhotra I, Liu S, Mahmoud AA & Oettgen HC. Mice with a targeted deletion of the IgE gene have increased worm burdens and reduced granulomatous inflammation following primary infection with Schistosoma mansoni. J Immunol 1997; 158: 294-300.
95. Mangold BL & Dean DA. Passive transfer with serum and IgG antibodies of irradiated cercaria-induced resistance against Schistosoma mansoni in mice. J Immunol 1986; 136: 2644-2648.
96. Delgado V & Mclaren DJ. Evidence for enhancement of IgG1 subclass expression in mice polyvaccinated with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity. Parasite Immunol 1990; 12: 15-32.
97. Wilson RA & Coulson PS. Strategies for a schistosome vaccine: can we manipulate the immune response effectively? Microbes Infect 1999; 1: 535-543.
98. Wynn TA & Hoffmann KF. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Parasitol Today 2000; 16: 497-501.
99. Pemberton RM & Wilson RA. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection. Immunology 1995; 84: 310-316.
100. Smythies LE, Betts C, Coulson PS, Dowling MA & Wilson RA. Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni. Parasite Immunol 1996; 18: 359-369.
101. Williams ME, Caspar P, Oswald I, et al. Vaccination routes that fail to elicit protective immunity against Schistosoma mansoni induce the production of TGF-beta, which down-regulates macrophage antiparasitic activity. J Immunol 1995; 154: 4693-4700.
102. von Lichtenberg F. Conference on contended issues of immunity to schistosomes. Am J Trop Med Hyg 1985; 34: 78-85.
103. Jenkins SJ, Hewitson JP, Ferret-Bernard S & Mountford AP. Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and independent pathways. Int Immunol, in press.